News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
369,152 Results
Type
Article (32017)
Company Profile (226)
Press Release (336909)
Multimedia
Podcasts (34)
Webinars (4)
Section
Business (92997)
Career Advice (304)
Deals (15595)
Drug Delivery (47)
Drug Development (63758)
Employer Resources (38)
FDA (10480)
Job Trends (7770)
News (180819)
Policy (16934)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (6)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (5)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (2)
2024 Genetown Digital (4)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (5)
2025 Lone Star Bio Digital (2)
2026 Bio NC Standard (1)
2026 Genetown Elite (1)
2026 Genetown Standard (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (1803)
Academic (1)
Accelerated approval (6)
Adcomms (20)
Allergies (49)
Alliances (26885)
ALS (94)
Alzheimer's disease (1479)
Antibody-drug conjugate (ADC) (74)
Approvals (10487)
Artificial intelligence (155)
Autoimmune disease (27)
Automation (9)
Bankruptcy (123)
Best Places to Work (7113)
BIOSECURE Act (4)
Biosimilars (82)
Biotechnology (164)
Bladder cancer (51)
Brain cancer (24)
Breast cancer (193)
Cancer (1631)
Cardiovascular disease (172)
Career advice (274)
Career pathing (7)
CAR-T (126)
Cell therapy (352)
Cervical cancer (18)
Clinical research (51884)
Collaboration (572)
Compensation (325)
Complete response letters (21)
COVID-19 (2223)
CRISPR (41)
C-suite (157)
Cystic fibrosis (97)
Data (1772)
Decentralized trials (1)
Denatured (1)
Depression (25)
Diabetes (195)
Diagnostics (4250)
Digital health (8)
Diversity (4)
Diversity, equity & inclusion (13)
Drug discovery (99)
Drug pricing (46)
Drug shortages (10)
Duchenne muscular dystrophy (94)
Earnings (34777)
Editorial (24)
Employer branding (6)
Employer resources (36)
Events (57796)
Executive appointments (434)
FDA (11382)
Featured Employer (39)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (505)
Gene editing (98)
Generative AI (11)
Gene therapy (282)
GLP-1 (527)
Government (2913)
Grass and pollen (1)
Guidances (30)
Healthcare (10044)
Huntington's disease (25)
IgA nephropathy (27)
Immunology and inflammation (116)
Indications (22)
Infectious disease (2372)
Inflammatory bowel disease (148)
Inflation Reduction Act (6)
Influenza (49)
Intellectual property (73)
Interviews (44)
IPO (8304)
IRA (22)
Job creations (1135)
Job search strategy (243)
Kidney cancer (10)
Labor market (7)
Layoffs (256)
Leadership (4)
Legal (2222)
Liver cancer (58)
Lung cancer (264)
Lymphoma (114)
Machine learning (5)
Management (9)
Manufacturing (123)
MASH (64)
Medical device (5083)
Medtech (5084)
Mergers & acquisitions (7650)
Metabolic disorders (494)
Multiple sclerosis (77)
NASH (21)
Neurodegenerative disease (106)
Neuropsychiatric disorders (19)
Neuroscience (1974)
NextGen: Class of 2025 (2974)
Non-profit (3058)
Northern California (1848)
Now hiring (8)
Obesity (238)
Opinion (130)
Ovarian cancer (55)
Pain (42)
Pancreatic cancer (69)
Parkinson's disease (158)
Partnered (7)
Patents (140)
Patient recruitment (77)
Peanut (25)
People (27593)
Pharmaceutical (53)
Pharmacy benefit managers (4)
Phase I (15658)
Phase II (23211)
Phase III (17582)
Pipeline (858)
Policy (69)
Postmarket research (1881)
Preclinical (6321)
Press Release (27)
Prostate cancer (84)
Psychedelics (17)
Radiopharmaceuticals (152)
Rare diseases (402)
Real estate (1848)
Recruiting (14)
Regulatory (13458)
Reports (15)
Research institute (1864)
Resumes & cover letters (35)
Rett syndrome (4)
RNA editing (4)
RSV (44)
Schizophrenia (59)
Series A (88)
Series B (60)
Service/supplier (2)
Sickle cell disease (56)
Southern California (1470)
Special edition (9)
Spinal muscular atrophy (157)
Sponsored (16)
Startups (2064)
Stomach cancer (9)
Supply chain (31)
Tariffs (6)
The Weekly (32)
United States (15009)
Vaccines (622)
Venture capitalists (22)
Weight loss (127)
Women's health (10)
Worklife (1)
Date
Last 7 days (313)
Last 30 days (1533)
Last 365 days (23112)
2025 (6465)
2024 (24345)
2023 (26693)
2022 (34973)
2021 (37283)
2020 (33535)
2019 (23809)
2018 (17992)
2017 (18573)
2016 (17477)
2015 (20092)
2014 (14709)
2013 (11232)
2012 (11368)
2011 (11441)
2010 (10679)
Location
Africa (387)
Alabama (35)
Alaska (4)
Arizona (56)
Arkansas (3)
Asia (22617)
Australia (4172)
California (4087)
Canada (1111)
China (363)
Colorado (130)
Connecticut (183)
Delaware (86)
Europe (53355)
Florida (531)
Georgia (121)
Idaho (30)
Illinois (261)
India (13)
Indiana (170)
Iowa (3)
Japan (132)
Kansas (34)
Kentucky (15)
Louisiana (7)
Maine (13)
Maryland (579)
Massachusetts (3318)
Michigan (100)
Minnesota (188)
Mississippi (1)
Missouri (39)
Montana (19)
Nebraska (7)
Nevada (37)
New Hampshire (15)
New Jersey (1262)
New Mexico (12)
New York (1182)
North Carolina (639)
North Dakota (3)
Northern California (1848)
Ohio (115)
Oklahoma (3)
Oregon (24)
Pennsylvania (885)
Puerto Rico (2)
Rhode Island (16)
South America (402)
South Carolina (3)
Southern California (1470)
Tennessee (30)
Texas (596)
Utah (122)
Virginia (86)
Washington D.C. (36)
Washington State (387)
Wisconsin (32)
369,152 Results for "cure rare disease".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NephCure Celebrates 25 Years Closer to a Cure for Rare Kidney Disease
February 6, 2025
·
3 min read
Funding
AIRNA Hits $155M Series B Haul To Advance RNA Editor for Rare Genetic Disease
AIRNA’s lead candidate AIR-001 works by correcting the most common pathologic mutation driving the rare disease alpha-1 antitrypsin deficiency.
April 1, 2025
·
2 min read
·
Tristan Manalac
Press Releases
CTNNB1 Foundation awarded €1M as Slovenia backs nonprofit gene therapy - a first step toward equitable cures for rare diseases
March 31, 2025
·
1 min read
Rare diseases
Glycomine Gets $115M Series C for Rare Disease, Aims for Phase II Launch Mid-Year
The raise will go toward trialing the company’s lead drug for phosphomannomutase-2 congenital disorder of glycosylation, a rare disease that affects the entire body and produces a wide range of symptoms.
April 16, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Cure Rare Disease Appoints Brittany Stineman as Chief Advancement Officer
December 18, 2024
·
2 min read
Business
Cure Rare Disease Expands Leadership Team and Board of Directors to Advance Mission
Cure Rare Disease, a clinical-stage nonprofit biotechnology organization, announces the addition of a Chief Advancement Officer to its leadership team and welcomes three new members to its board of directors.
June 17, 2024
·
3 min read
Press Releases
Cure Rare Disease Awarded $5.69 Million CIRM Grant to Advance Gene Therapy for Spinocerebellar Ataxia Type 3
February 7, 2025
·
3 min read
Rare diseases
How SpringWorks Took Pfizer’s Rare Disease Ghost Drug and Got It to Patients
SpringWorks Therapeutics sprung out of Pfizer’s storeroom, when a rare disease advocacy group pushed to keep a program for neurofibromatosis alive. This method could work for “every rare disease under the sun,” advocates say.
February 26, 2025
·
5 min read
·
Annalee Armstrong
Press Releases
Child’s Cure Genetic Research collaborates with Matica Bio to Drive Innovation in Pediatric Rare Disease Therapies
January 7, 2025
·
3 min read
Press Releases
Quoin Pharmaceuticals Launches ‘NETHERTON NOW’ Campaign to Raise Awareness of Netherton Syndrome, a Rare Genetic Disease with No Approved Treatment or Cure
February 4, 2025
·
7 min read
1 of 36,916
Next
